A Director at Biolase is Exercising Options

By Carrie Williams

Today, a Director at Biolase, James Talevich, exercised options of Biolase for $1,435. The options were close to expired and James Talevich retained stocks.

Following this transaction James Talevich’s holding in the company was increased by 5.17% to a total of $27.59K.

Currently, Biolase has an average volume of 376.8K. The company has a one-year high of $1.90 and a one-year low of $0.28.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

BIOLASE, Inc. is a medical technology company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners, in-office, chair-side milling machines and three-dimensional printers.